BMRN vs INTZ · P/E 40, rev $1.76B vs rev $2.3M
Biomarin Pharmaceutical Inc (BMRN) versus Intrusion Inc (INTZ) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Intrusion Inc (INTZ) is a software - infrastructure company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported INTZ revenue for 2026-06-30 was $2.3M. Net income was -$6.2M. INTZ currently screens at market cap $15.7M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. INTZ currently screens at market cap $15.7M.
Not investment advice. Open the BMRN and INTZ stock pages for the full models.
Not investment advice.